CMS Rule Requires Disclosure of Industry Payments to Physicians, Teaching Hospitals

CMS last week published a proposed rule intended to create more  transparency about financial relationships between doctors and  drugmakers, device manufacturers and other private interests.  The  proposal would require manufacturers of drugs, devices, biologicals, and  medical supplies covered by Medicare, Medicaid, or the Children’s Health  Insurance Program to report to CMS payments or other transfers of value  they make to physicians and teaching hospitals.  The proposed rule would  also require manufacturers and group purchasing organizations (GPOs) to  disclose to CMS physician ownership or investment interests. Click here for more.


© 2011–2016 National Minority Quality Forum, Inc. All Rights Reserved.